HOME >> MEDICINE >> NEWS
Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia

Scientists presented promising data today at the 35th Annual Meeting of the American Society of Clinical Oncology (ASCO) on the use of a pioneering drug technology known as "antibody-targeted chemotherapy" to fight acute myelogenous leukemia (AML) - a virulent and often fatal form of cancer. The experimental agent, CMA-676, induces remission in a significant proportion of patients with few serious side effects. CMA-676 represents the first successful application of antibody-targeted chemotherapy.

AML is an aggressive, life-threatening disease in which certain white blood cells become cancerous and rapidly replace normal bone marrow and blood cells. AML is among the most serious forms of adult leukemia, with a relatively high fatality rate. Most patients require intensive chemotherapy to achieve complete remission, and some also must undergo bone marrow transplants. Up to half of patients with AML, even after such intensive treatment, have residual leukemic cells or experience a relapse.

Because current chemotherapy drugs to treat AML are non-specific - destroying good as well as bad cells - patients receiving standard chemotherapy tend to become very sick. Researchers at the Fred Hutchinson Cancer Research Center, in collaboration with scientists from thirteen leading leukemia centers, including University of Chicago Medical Center, MD Anderson Cancer Center, and the University of Pennsylvania Cancer Center, are working with Wyeth-Ayerst Research and Celltech PLC to study CMA-676, an antibody-drug conjugate that delivers treatment directly to the leukemia cells.

The specificity of the conjugate lies in the antibody, which recognizes a cell-surface molecule that is abundant on AML cells. Importantly, however, the cell surface molecule is absent from normal blood stem cells, the seeds from which normal blood and immune cells originate. Specially engineered to carry a novel and extremely potent chemotherapy agent known as calicheamic
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
16-May-1999


Page: 1 2

Related medicine news :

1. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
2. Breakthrough therapies treat Crohns disease
3. Breakthrough cancer treatment Avastin receives first approval in the US
4. Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy
5. Breakthrough in hormonal breast cancer therapy
6. Breakthrough! UNC scientists research promises improved X-ray machines using carbon nanotubes
7. Breakthrough pain in cancer associated with need for increased medical services, higher medical costs
8. Simple test predicts ability to grow new blood vessels: Breakthrough in battle against heart disease, diabetes, cancer
9. Low-Tech Treatment Proves A Life-Saver In Research Breakthrough
10. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain
11. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ARLINGTON, Va. (PRWEB) , ... June 22, 2020 , ... ... Information updated market sizes and forecasts for the market for tests tied to therapeutic ... surveyed oncology treatment centers in hospitals, as well as pharmaceutical companies serving them to ...
(Date:6/23/2020)... ... June 22, 2020 , ... A June 1 article on ... of the country slowly opening back up while adjusting to new rules regarding public ... the face that aren’t covered such as eyelids, lashes, and brows. Beverly Hills Permanent ...
(Date:6/23/2020)... ... June 22, 2020 , ... The COVID-19 pandemic has set the stage for ... Frost & Sullivan survey predicts a sevenfold growth in telehealth services by ... services to receive care. , SPH Analytics , a leader ...
(Date:6/23/2020)... ... ... Advanced Kiosks , an industry-leading supplier of computer self-service kiosks, has announced ... building access control resulting from the COVID-19 pandemic, Advanced Kiosks is releasing the ... products and services to meet the demands of their customers. Already in 2020 they ...
(Date:6/21/2020)... SUN VALLEY, Calif. (PRWEB) , ... June 20, ... ... Narcotic Addiction Treatment Agency (NATA), an Opioid Treatment Program (OTP) in Sun Valley, ... 35 years, NATA has established themselves as a key provider of comprehensive treatment ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... ... launch one of the first online COVID-19 trainings for health workers and others ... this free training entitled COVID-19 Training for Health Workers: Preparedness and Response ...
(Date:6/23/2020)... ... June 23, 2020 , ... Construction at the Kasemrad ... features a greatly enlarged and enhanced medical facility. Penetron crystalline technology ... and rooftop garden. , Part of the Bangkok Chain Hospital (BCH) network of ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... (EGRI) , a comprehensive recovery index that combines three sub-indices that COVID-19 has ... seeks to provide a holistic way of looking at these three areas at ...
Breaking Medicine Technology:
Cached News: